Amphetamine (Dyanavel-XR®) extended-release oral suspension: Basic information

Amphetamine (US brand name Dyanavel-XR®) extended-release oral suspension is a central nervous system (CNS) stimulant. Here is more information about this medication.

FDA-approved indications

Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Dosage

Starting dose: 2.5 mg or 5 mg once daily in the morning (ages 6 or more)

Titration: Increments of 2.5 mg to 10 mg per day every 4 to 7 days until optimal response is obtained

Maximum: 20 mg per day

Dosing Instructions

Shake bottle before administering the dose
May be taken with or without food

Switching from other Amphetamine Products

If switching from other amphetamine products, discontinue that treatment, and titrate with Dyanavel XR® using the above titration schedule. Do not substitute for other amphetamine products on a milligram-per-milligram basis, because of different amphetamine base compositions and differing pharmacokinetic profiles.

Dosage forms and strengths

Extended-release oral suspension: 2.5 mg amphetamine base per mL

Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.

Amphetamine preparations

Tips for prescribing ADHD medications

Converting stimulants: Equivalent doses

Stimulants: Main page (links to all pages on this topic)

References

Prescribing information for amphetamine (Dyanavel-XR®) extended-release oral suspension

Disclaimer: The material on this website is provided as general education for medical professionals. It is not intended for patients or other laypersons, nor is it a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified healthcare professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most up-to-date information.